#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Porphyria non-acute Krabbe's disease Choroidal dystrophy Vulval cancer Brain abscess Meningococcal immunisation Primitive neuroectodermal tumour PIK3CA related overgrowth spectrum Pulmonary hypertension Pyruvate dehydrogenase complex deficiency Hyperinsulinism Metabolic disorder Non-Hodgkin's lymphoma Metastases to peritoneum Advanced systemic mastocytosis More trials…

    Learn about Rare Diseases

    Breast angiosarcoma – Life with Disease Congenital generalised lipodystrophy – Diagnostics Antithrombin III deficiency Malignant fibrous histiocytoma – Life with Disease Hyperoxaluria – Basic Information Andersen-Tawil syndrome – Treatment Haemophilia B without inhibitors – Treatment Turner’s syndrome – Trials in Disease Isodicentric chromosome 15 syndrome – Treatment Ewing’s sarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amantadine Hydrochloride Tucatinib Ferumoxytol Ademetionine CYCLIZINE HYDROCHLORIDE Travoprost Iptacopan Hydrochloride Safinamide Cloxacillin Sodium Berzosertib Efruxifermin Crgd-Zw800-1 Fluoroestradiol F-18 Treprostinil Palmitil Febuxostat Hemihydrate Amphotericin B Esk-001 Metoprolol Allopurinol Sodium Db-Oto-3 More therapies…

    Learn about Your Condition

    Pain in extremity Large cell lung cancer Short-bowel syndrome Appendicitis Hyperparathyroidism primary Autism spectrum disorder Renal cancer stage IV Ischaemic stroke Prostate cancer metastatic Marginal zone lymphoma Hyperchylomicronaemia Systemic lupus erythematosus Left ventricular failure Venous thrombosis Hepatic cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute myeloid leukaemia

  • Study on Stopping Venetoclax and Azacitidine in Patients with Acute Myeloid Leukemia Who Are Responding to Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    France

  • Study of Ziftomenib with Chemotherapy for Children with Relapsed or Refractory Acute Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Ziftomenib
    • Fludarabine Phosphate
    • Cytarabine
    Austria France Italy The Netherlands Spain

  • Study on Teicoplanin for Preventing Infections in Children with Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Teicoplanin
    Belgium Denmark The Netherlands Spain

  • Study on Mocravimod for Adults with Acute Myeloid Leukemia Undergoing Stem Cell Transplant

    Recruiting

    3 1
    Investigated Drugs:
    • Mocravimod
    France Germany Italy Poland Romania Spain

  • Study of Gilteritinib, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutations Not Eligible for Intensive Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gilteritinib
    • Azacitidine
    • Venetoclax
    Germany

  • Study of azacitidine combined with low-dose venetoclax treatment for patients with acute myeloid leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Cedazuridine
    • Decitabine
    Denmark Finland Norway Sweden
Previous Page
1 … 3 4 5 6 7 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!